Literature DB >> 12384397

Enzyme-catalyzed antimicrobial activation.

J M T Hamilton-Miller.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 12384397      PMCID： PMC128745          DOI： 10.1128/AAC.46.11.3692.2002

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  8 in total

Review 1.  beta-lactams: variations on a chemical theme, with some surprising biological results.

Authors:  J M Hamilton-Miller
Journal:  J Antimicrob Chemother       Date:  1999-12       Impact factor: 5.790

2.  A new cephalosporin with a dual mode of action.

Authors:  C H O'Callaghan; R B Sykes; S E Staniforth
Journal:  Antimicrob Agents Chemother       Date:  1976-08       Impact factor: 5.191

Review 3.  Dual-action antibiotic hybrids.

Authors:  J M Hamilton-Miller
Journal:  J Antimicrob Chemother       Date:  1994-02       Impact factor: 5.790

4.  NB2001, a novel antibacterial agent with broad-spectrum activity and enhanced potency against beta-lactamase-producing strains.

Authors:  Qing Li; Jean Y Lee; Rosario Castillo; Mark S Hixon; Catherine Pujol; Venkata Ramana Doppalapudi; H Michael Shepard; Geoffrey M Wahl; Thomas J Lobl; Ming Fai Chan
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

5.  A novel approach to thymidylate synthase as a target for cancer chemotherapy.

Authors:  Q Li; C Boyer; J Y Lee; H M Shepard
Journal:  Mol Pharmacol       Date:  2001-03       Impact factor: 4.436

6.  Triclosan: applications and safety.

Authors:  H N Bhargava; P A Leonard
Journal:  Am J Infect Control       Date:  1996-06       Impact factor: 2.918

7.  Enzyme-catalyzed therapeutic agent (ECTA) design: activation of the antitumor ECTA compound NB1011 by thymidylate synthase.

Authors:  D B Lackey; M P Groziak; M Sergeeva; M Beryt; C Boyer; R M Stroud; P Sayre; J W Park; P Johnston; D Slamon; H M Shepard; M Pegram
Journal:  Biochem Pharmacol       Date:  2001-01-15       Impact factor: 5.858

8.  Cephalosporin derivatives of doxorubicin as prodrugs for activation by monoclonal antibody-beta-lactamase conjugates.

Authors:  V M Vrudhula; H P Svensson; P D Senter
Journal:  J Med Chem       Date:  1995-04-14       Impact factor: 7.446
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.